Patient Guide: Maintenance Pembrolizumab at Usual or Low doSE in Non-squamous Lung Cancer: a Non-inferiority Study

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 37 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05692999
Status: 🟢 Enrolling Now
Condition: Metastatic Non-squamous Lung Cancer
Phase: PHASE3

Where You Can Participate

This study is available at 37 locations across the country.

Top locations include:
  • • Namur,
  • • Carcassonne, Aude
  • • Strasbourg, Bas-Rhin
  • • And 34 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Maintenance Pembrolizumab at Usual or Low doSE in Non-squamous Lung Cancer: a Non-inferiority Study - Join Clinical Trial NCTNCT05692999

How to Join This Clinical Trial - NCTNCT05692999

Learn how to participate in this PHASE3 trial studying an investigational therapy for Metastatic Non-squamous Lung Cancer. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Metastatic Non-squamous Lung Cancer. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Metastatic Non-squamous Lung Cancer
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT05692999 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 37 locations. Find a study site near you:

Clinical Research Site

Namur, B-5000 - Belgium

Status: RECRUITING

Clinical Research Site

Carcassonne, Aude 11810 - France

Status: RECRUITING

Clinical Research Site

Strasbourg, Bas-Rhin 67000 - France

Status: RECRUITING

Clinical Research Site

Strasbourg, Bas-Rhin 67200 - France

Status: RECRUITING

Clinical Research Site

Marseille, Bouches-du-Rhône 13003 - France

Status: RECRUITING

Clinical Research Site

La Rochelle, Charente-Maritime 17000 - France

Status: RECRUITING

Clinical Research Site

Brest, Finistère 29609 - France

Status: RECRUITING

Clinical Research Site

Morlaix, Finistère 29600 - France

Status: RECRUITING

Clinical Research Site

Mulhouse, Haut-Rhin 68100 - France

Status: RECRUITING

Clinical Research Site

Tarbes, Hautes-Pyrénées 65000 - France

Status: RECRUITING

And 27 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Metastatic Non-squamous Lung Cancer:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships